Watch an on-demand Webcast from a live Webinar in which CCO’s expert faculty provides insights on the most clinically relevant new data presented at The IAS COVID-19 Conference: Prevention, 2021.
Advances in vaccine technologies and trials are leading to robust data for global vaccination efforts. Current vaccines have varying degrees of efficacy, and emerging variants are creating further deviation, suggesting a need for a rapid increase in vaccinations as well as improved molecular surveillance.
Data demonstrate potential for monoclonal antibodies in treatment and prevention of COVID-19 in select patients. Emergence of variants may affect current and future utility and will necessitate discernment from healthcare professionals.
In this downloadable slideset, CCO’s expert faculty summarizes important studies from this timely conference, including new IAS data on COVID-19 transmission and prevention.
Hear insights from Jens D. Lundgren, MD, DMSc, on some of the most important COVID-19 prevention data reported at the 2021 IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.